Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human CYP7A1 Antikörper:
anti-Mouse (Murine) CYP7A1 Antikörper:
anti-Rat (Rattus) CYP7A1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal CYP7A1 Primary Antibody für IF (p), IHC (p) - ABIN739725
Gabbi, Bertolotti, Anzivino, Macchioni, Del Puppo, Ricchi, Carubbi, Tagliafico, Romagnoli, Odoardi, Loria, Losi, Carulli: Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012
Show all 7 Pubmed References
The analysis of the relationship of polymorphic variants CYP7A1 to lipid metabolic disturbances makes it possible to consider the AA homozygous genotype of variant mutation CYP7A1 rs 38088607 as protective against Dyslipidemia.
Genetic polymorphisms of CYP7A1 may be associated with susceptibility to anti-tuberculosis drug-induced hepatotoxicity in the Chinese population
Current studies suggest that increased Cyp7a1 expression and bile acid synthesis ameliorate hepatic inflammation through activation of FXR (zeige NR1H4 Antikörper)
This study provides evidence that individuals carrying the G allele of CYP7A1 single nucleotide polymorphism are more responsive to high molecular weight beta-glucan's effect of lowering circulating cholesterol concentrations than individuals homozygous for the T allele.
Genetic variations in ABCG5 (zeige ABCG5 Antikörper), CYP7A1, and DHCR7 (zeige DHCR7 Antikörper) may contribute to differing responses of serum cholesterol to dairy intake among healthy adults.
The promoter polymorphism of the CYP7A1 gene has a pronounced impact on diurnal variation in CYP7A1 activity.
The finding that overexpression of HIF-1alpha (zeige HIF1A Antikörper) increased the activity of the CYP7A1 promoter suggested that hypoxia decreased the expression of CYP7A1 in a HIF-1 (zeige HIF1A Antikörper)-independent manner.
Macrophage cholesterol efflux in patients with type II diabetes mellitus was significantly reduced, and that this reduction was associated with the down-regulation of CYP7A1 expression.
CYP7A1 and APOE (zeige APOE Antikörper) isoform are associated with the extent of reduction in circulating LDL cholesterol in response to plant sterols consumption.
The CYP7A1 rs7833904 polymorphism may modify the risk of CAD (zeige CAD Antikörper).
Hypercholesterolemia in TALLYHO/jng mice might increase the Bile acids amounts via the interrupted Fxr (zeige NR1H4 Antikörper)/Fgf15/Fgfr4 (zeige FGFR4 Antikörper)-mediated feedback regulation of Cyp7a1.
although feeding LS-Xbp1 (zeige XBP1 Antikörper)(-/-) mice cholesterol did not increase CYP7A1 expression, serum C4 levels increased significantly up to levels similar to chow-fed Xbp1 (zeige XBP1 Antikörper)(fl/fl (zeige FLT3LG Antikörper)) mice and the total bile acid pool normalized. In conclusion, loss of hepatic XBP1 (zeige XBP1 Antikörper) decreased the bile acid pool and CYP7A1 synthetic activity.
Cyp7a1(-/-) mice have improved glucose sensitivity with reduced liver triglycerides and fecal bile acid excretion, but increased fecal fatty acid excretion and respiratory exchange ratio (RER) when fed a high-fat/high-cholesterol diet
HSF-1 (zeige HSF1 Antikörper) ablation not only eliminates heat shock response, but it also transcriptionally up-regulates CYP7A1 and MDR1/P-gp (zeige ABCB4 Antikörper) axis in WD-diet fed HSF-1 (zeige HSF1 Antikörper)(-/-)/LDLr (zeige LDLR Antikörper)(-/-) mice to reduce atherosclerosis.
Mice deficient in cholesterol 7 alpha-hydroxylase, supplemented with chenodeoxycholic acid, have altered liver and intestinal bile acids.
Activation of the VDR (zeige CYP27B1 Antikörper) represses hepatic SHP (zeige LAMC1 Antikörper) to increase levels of CYP7A1 and reduce cholesterol.
Cholesterol lowering properties of oats involve increased production of bile acids via the classic pathway with up-regulation of CYP7A1 and CYP8B1 (zeige CYP8B1 Antikörper).
A CYP7A1/SREBP2 (zeige SREBF2 Antikörper)/miR (zeige MLXIP Antikörper)-33a axis plays a critical role in regulation of hepatic cholesterol, bile acid, and fatty acid synthesis.
Ileal Fibroblast Growth Factor-15 (FGF15) expression was significantly reduced in Asbt (zeige SLC10A2 Antikörper)(-/-)apoE (zeige APOE Antikörper)(-/-) mice and was inversely correlated with expression of hepatic cholesterol 7-hydroxylase (Cyp7a1).
the effect of polymorphism in the cholesterol 7-alpha hydroxylase gene locus and dietary cholesterol on cerebrum cholesterol in neonatal pigs fed sow's milk formulas are reported.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway in the liver, which converts cholesterol to bile acids. This reaction is the rate limiting step and the major site of regulation of bile acid synthesis, which is the primary mechanism for the removal of cholesterol from the body. Polymorphisms in the promoter of this gene are associated with defects in bile acid synthesis.
, cholesterol 7-alpha-monooxygenase
, cytochrome P450 7A1
, cytochrome P450, subfamily VIIA polypeptide 1
, cholesterol 7 alpha hydroxylase
, cytochrome P450, 7a1
, cholesterol 7-alpha hydroxylase
, cytochrome P450 (cholesterol hydroxylase 7 alpha)
, cholesterol 7alpha-hydroxylase
, cholesterol 7 alpha-hydroxylase